The forecasted antiretroviral therapy coverage for male adults living with HIV in Brazil indicates a steady increase from 78% in 2024 to 86% in 2028. This is a positive trend compared to the approximate value of 76% in 2023, demonstrating a consistent year-on-year growth of around 2.5%. This suggests ongoing improvements in healthcare initiatives targeting HIV in Brazil.
Future trends to watch for include the potential impact of emerging healthcare technologies and policies designed to further increase therapy coverage. Additionally, monitoring the sustainability of funding and resource allocation will be essential for maintaining and enhancing this growth trend.
